These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23934561)

  • 1. Determining the concentration of procalcitonin using a magnetic particles-based chemiluminescence assay for the clinical diagnosis of sepsis.
    Qi S; Li Q; Rao W; Liu X; Yin L; Zhang H
    Anal Sci; 2013; 29(8):805-10. PubMed ID: 23934561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a rapid and high-performance chemiluminescence immunoassay based on magnetic particles for protein S100B in human serum.
    Zhang H; Qi S; Rao J; Li Q; Yin L; Lu Y
    Luminescence; 2013; 28(6):927-32. PubMed ID: 23319388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rapid and sensitive chemiluminescence immunoassay based on magnetic particles for squamous cell carcinoma antigen in human serum.
    Zhang H; Qi S
    Clin Chim Acta; 2011 Aug; 412(17-18):1572-7. PubMed ID: 21600892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of procalcitonin concentration using the SphereLight 180 clinical auto-analyzer.
    Yamada H; Matsuda S; Ushio Y; Nakamura K; Kobatake S; Satomura S; Matsuura S
    Clin Chim Acta; 2008 Feb; 388(1-2):38-40. PubMed ID: 18021760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of measurement method of a bacterial sepsis marker, procalcitonin].
    Adachi S; Nakao K
    Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2010; 21(2):107-9. PubMed ID: 22096868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total internal reflection (TIRF)-based quantification of procalcitonin for sepsis diagnosis--a point-of-care testing application.
    Rascher D; Geerlof A; Kremmer E; Krämer P; Michael S; Hartmann A; Rieger M
    Biosens Bioelectron; 2014 Sep; 59():251-8. PubMed ID: 24732603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a fully automated procalcitonin chemiluminescence immunoassay.
    Hubl W; Krassler J; Zingler C; Pertschy A; Hentschel J; Gerhards-Reich C; Mack M; Demant T
    Clin Lab; 2003; 49(7-8):319-27. PubMed ID: 12908732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new ELISA for the quantification of equine procalcitonin in plasma as potential inflammation biomarker in horses.
    Rieger M; Kochleus C; Teschner D; Rascher D; Barton AK; Geerlof A; Kremmer E; Schmid M; Hartmann A; Gehlen H
    Anal Bioanal Chem; 2014 Sep; 406(22):5507-12. PubMed ID: 24928115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of high-performance magnetic chemiluminescence enzyme immunoassay for alpha-fetoprotein (AFP) in human serum.
    Wang X; Zhang QY; Li ZJ; Ying XT; Lin JM
    Clin Chim Acta; 2008 Jul; 393(2):90-4. PubMed ID: 18402780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers in the critically ill patient: procalcitonin.
    Reinhart K; Meisner M
    Crit Care Clin; 2011 Apr; 27(2):253-63. PubMed ID: 21440200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Usefulness of Procalcitonin Measurement for the Detection of Sepsis].
    Toh H; Harada S; Kakudou T; Era F; Tokushige C; Yoshimura H; Kawashima H; Ohkubo K; Ishikura H; Matsunaga A
    Rinsho Byori; 2014 Oct; 62(10):931-6. PubMed ID: 27526537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a fluorescent immnunochromatographic assay for the procalcitonin detection of clinical patients in China.
    Wang H; Wang H; Chen S; Dzakah EE; Kang K; Wang J; Wang J
    Clin Chim Acta; 2015 Apr; 444():37-42. PubMed ID: 25659293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoluminometric detection of human procalcitonin.
    Köszegi T
    J Biochem Biophys Methods; 2002; 53(1-3):157-64. PubMed ID: 12406598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum procalcitonin and C-reactive protein as markers of sepsis and outcome in patients with neurotrauma and subarachnoid haemorrhage.
    Oconnor E; Venkatesh B; Mashongonyika C; Lipman J; Hall J; Thomas P
    Anaesth Intensive Care; 2004 Aug; 32(4):465-70. PubMed ID: 15675205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective evaluation of procalcitonin in sepsis in the Illawarra area of Australia: PEPSIA study.
    Muthiah KA; Rachakonda KS; Davis MJ; Simmons EG; Schier G; Gil FS
    Crit Care Resusc; 2007 Jun; 9(2):137-42. PubMed ID: 17536980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procalcitonin: a valuable indicator of infection in a medical ICU?
    Suprin E; Camus C; Gacouin A; Le Tulzo Y; Lavoue S; Feuillu A; Thomas R
    Intensive Care Med; 2000 Sep; 26(9):1232-8. PubMed ID: 11089747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of procalcitonin as a marker of sepsis: a potential predictor of causative pathogens.
    Nakajima A; Yazawa J; Sugiki D; Mizuguchi M; Sagara H; Fujisiro M; Shibazaki M; Hitani A; To M; Haruki K
    Intern Med; 2014; 53(14):1497-503. PubMed ID: 25030560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of soluble intercellular adhesion molecule-1 and procalcitonin in diagnosis of neonatal septicemia].
    Ma L; Liu CQ; Liu ZH; Liu SZ; Jia XQ; Li WJ; Hu HF
    Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):654-8. PubMed ID: 15482664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic values of procalcitonin, interleukin-6, C reactive protein and serum amyloid A in sepsis].
    Fu Y; Chen J; Cai B; Zhang JL; Li LX; Wang LL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 43(5):702-5. PubMed ID: 23230743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of procalcitonin for diagnosis of neonatal sepsis of vertical transmission.
    López Sastre JB; Solís DP; Serradilla VR; Colomer BF; Cotallo GD;
    BMC Pediatr; 2007 Feb; 7():9. PubMed ID: 17324267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.